Why iBio Stock Soared Today

Why iBio Stock Soared Today
Joe Tenebruso, The Motley Fool
·1 min read

Cantor Fitzgerald analyst Kristen Kluska placed an overweight rating on iBio's stock after the market close on Thursday. Kluska says iBio's stock is largely under the radar of most investors and that its current price fails to reflect the company's position as a leader in plant-based biologics manufacturing.